Catalyst Wire Dossier Catalyst Wire Dossier

Opaganib

opaganib
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Opaganib, covering 2022-03-21 to 2025-07-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma [Phase 2]

See pricing